BlackRock’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$173K Sell
31,335
-15,056
-32% -$83.1K ﹤0.01% 4633
2025
Q1
$267K Sell
46,391
-14,241
-23% -$82.1K ﹤0.01% 4500
2024
Q4
$561K Sell
60,632
-188
-0.3% -$1.74K ﹤0.01% 4327
2024
Q3
$1,000K Sell
60,820
-2,612
-4% -$42.9K ﹤0.01% 4125
2024
Q2
$1.21M Sell
63,432
-13
-0% -$248 ﹤0.01% 4077
2024
Q1
$1.7M Sell
63,445
-10,730
-14% -$287K ﹤0.01% 4000
2023
Q4
$1.01M Sell
74,175
-667
-0.9% -$9.13K ﹤0.01% 4174
2023
Q3
$1.16M Sell
74,842
-2,268
-3% -$35.1K ﹤0.01% 4137
2023
Q2
$1.67M Buy
77,110
+75
+0.1% +$1.62K ﹤0.01% 4051
2023
Q1
$1.37M Sell
77,035
-10,196
-12% -$181K ﹤0.01% 4141
2022
Q4
$1.48M Sell
87,231
-16,675
-16% -$282K ﹤0.01% 4181
2022
Q3
$3.43M Sell
103,906
-1,472
-1% -$48.6K ﹤0.01% 3847
2022
Q2
$5.94M Sell
105,378
-132
-0.1% -$7.44K ﹤0.01% 3667
2022
Q1
$6.15M Buy
105,510
+1,999
+2% +$117K ﹤0.01% 3765
2021
Q4
$7.45M Buy
103,511
+1,011
+1% +$72.8K ﹤0.01% 3759
2021
Q3
$8.29M Buy
102,500
+2,109
+2% +$171K ﹤0.01% 3701
2021
Q2
$9.68M Sell
100,391
-79,456
-44% -$7.66M ﹤0.01% 3592
2021
Q1
$21.6M Buy
179,847
+53,627
+42% +$6.44M ﹤0.01% 3095
2020
Q4
$16.5M Buy
126,220
+23,821
+23% +$3.12M ﹤0.01% 3046
2020
Q3
$10.8M Buy
102,399
+11,912
+13% +$1.26M ﹤0.01% 3104
2020
Q2
$23.3M Sell
90,487
-2,180
-2% -$561K ﹤0.01% 2676
2020
Q1
$41.2M Buy
92,667
+816
+0.9% +$363K ﹤0.01% 2157
2019
Q4
$62.1M Buy
91,851
+71,879
+360% +$48.6M ﹤0.01% 2214
2019
Q3
$7.39M Buy
19,972
+8,664
+77% +$3.21M ﹤0.01% 3319
2019
Q2
$2.03M Buy
+11,308
New +$2.03M ﹤0.01% 3727